Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
Spotlight on OHE: Understanding Value Based Pricing
12 February 2013
Value based pricing (VBP) is increasingly common in health care systems worldwide. OHE continues to make important contributions to the debate about VBP approaches and application…
New Pilot Study: Capturing Public Preferences about Health Care Priorities
16 January 2013
The proposals from the UK Department of Health (DH) for value based pricing (VBP) include a process whereby higher prices would be granted to medicines that…
Searching for Cost-effectiveness Thresholds in NHS Scotland
1 December 2013
This research examines the use of QALY thresholds in NHS Scotland in 2012-13 for health services that were “at the margin”, i.e. those for which investment or…
The challenges and economics of drug development in 2022
1 July 2013
Based on OHE’s 50th anniversary conference, this publication captures the views of thought leaders from around the world about the scientific and economic climate for drug…
What constitutes credible evidence of effectiveness
1 June 2013
In this monograph based his remarks at the 19th OHE Annual Lecture, Professor Sir Michael Rawlins examines the standards of proof required to show the effectiveness…
Exploring the link between health and wealth in decision making
1 May 2013
Is the Link Between Health and Wealth Considered in Decision Making? Results from a Qualitative Study Is the Link Between Health and Wealth Considered in Decision…
Multi-Criteria Decision Analysis to Value Orphan Medicines
1 May 2013
The purpose of this research is to identify the attributes to include in a value framework for orphan medicinal products (OMPs), determine their relative importance using…
Projecting Expenditure on Medicines in the NHS
4 January 2013
Medicines account for less than 10% of total NHS expenditure in the UK. Because spending on medicines is easy to separate out, however, this sector continues…
New Research by OHE and University of Glasgow on cost of QALYs in Scotland
17 December 2012
New health care technologies often improve health but also increase costs. Judging whether they are good value for money involves comparing what QALYs are gained from…